Insmed (INSM) EBT (2010 - 2026)
Insmed's (INSM) quarterly EBT came in at -$162.1 million in Q1 2026, up 36.6% year-on-year from -$118.7 million in Q1 2025, and up 50.42% quarter-over-quarter from -$326.9 million in Q4 2025.
Insmed (INSM) EBT (2010 - 2026) Analysis & Trends
Insmed's EBT history runs 17 years deep, the most recent figure standing at -$162.1 million for Q1 2026.
- On a quarterly basis, EBT rose 36.6% year-over-year to -$162.1 million in Q1 2026; TTM through Mar 2026 was -$1.2 billion, a 16.74% decrease from a year earlier, with the FY2025 full-year figure at -$1.3 billion, down 39.74% from the prior year.
- EBT improved to -$162.1 million in Q1 2026 per INSM's latest filing, from -$326.9 million in the prior quarter.
- Across five years, EBT topped out at -$94.2 million in Q1 2022 and bottomed at -$368.7 million in Q3 2025.
- The 5-year median for EBT is -$185.1 million (2023), against an average of -$210.1 million.
- Across the five-year window, EBT slumped 156.75% in 2023 and surged 36.6% in 2026, its largest moves.
- Year by year, EBT stood at -$160.0 million in 2022, then decreased by 15.67% to -$185.1 million in 2023, then slipped by 26.6% to -$234.3 million in 2024, then tumbled by 39.55% to -$326.9 million in 2025, then jumped by 50.42% to -$162.1 million in 2026.
- Per Business Quant, the three latest INSM EBT figures stand at -$162.1 million (Q1 2026), -$326.9 million (Q4 2025), and -$368.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Insmed | 23.02 Bn | 21.80 Bn | 258.54 Mn | -162.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -162.10 Mn |
| Dec 31, 2025 | -326.93 Mn |
| Sep 30, 2025 | -368.70 Mn |
| Jun 30, 2025 | -320.44 Mn |
| Mar 31, 2025 | -255.67 Mn |
| Dec 31, 2024 | -234.28 Mn |
| Sep 30, 2024 | -219.51 Mn |
| Jun 30, 2024 | -299.77 Mn |
| Mar 31, 2024 | -156.50 Mn |
| Dec 31, 2023 | -185.06 Mn |
| Sep 30, 2023 | -158.39 Mn |
| Jun 30, 2023 | -244.28 Mn |
| Mar 31, 2023 | -159.28 Mn |
| Dec 31, 2022 | -160.00 Mn |
| Sep 30, 2022 | -130.77 Mn |
| Jun 30, 2022 | -95.14 Mn |
| Mar 31, 2022 | -94.24 Mn |
| Dec 31, 2021 | -113.02 Mn |
| Sep 30, 2021 | -115.29 Mn |
| Jun 30, 2021 | -116.70 Mn |